A Komen-funded study from Michigan State University shows that effective breast cancer treatment options can be predicted based on the way certain breast cancer genes act or express themselves. The study paves the way for more targeted and personalized approaches to care, especially for breast cancers with limited treatment options, like triple negative.

Read the Science Daily article for more information.